dc.creator | Egea, Ana L | |
dc.creator | Gagetti, Paula | |
dc.creator | Lamberghini, Ricardo | |
dc.creator | Faccone, Diego | |
dc.creator | Lucero, Celeste | |
dc.creator | Vindel, Ana | |
dc.creator | Tosoroni, Dario | |
dc.creator | Garnero, Analía | |
dc.creator | Saka, Héctor A. | |
dc.creator | Galas, Marcelo F. | |
dc.creator | Bocco, Jose Luis | |
dc.creator | Corso, Alejandra | |
dc.creator | Sola, Claudia | |
dc.creator | S. aureus Study Group Argentina | |
dc.date | 2021-02-01T20:10:24Z | |
dc.date | 2021-02-01T20:10:24Z | |
dc.date | 2014-11 | |
dc.date.accessioned | 2023-08-29T20:09:16Z | |
dc.date.available | 2023-08-29T20:09:16Z | |
dc.identifier | 1618-0607 | |
dc.identifier | http://sgc.anlis.gob.ar/handle/123456789/2275 | |
dc.identifier | 10.1016/j.ijmm.2014.08.002 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8520590 | |
dc.description | Fil: Egea, Ana L. Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina. Centro de Investigaciones en Bioquímica Clínica e Inmunología. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. | |
dc.description | Fil: Gagetti, Paula. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio Antimicrobianos; Argentina. | |
dc.description | Fil: Lamberghini, Ricardo. Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. Cátedra de Infectología I. Hospital Rawson; Argentina. | |
dc.description | Fil: Faccone, Diego. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio Antimicrobianos; Argentina. | |
dc.description | Fil: Lucero, Celeste. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio Antimicrobianos; Argentina. | |
dc.description | Fil: Vindel, Ana. Centro Nacional de Microbiología. Instituto de Salud Carlos III. Laboratorio de Infecciones Nosocomiales; España. | |
dc.description | Fil: Tosoroni, Dario. Universidad Católica de Córdoba. Facultad de Medicina. Área de Informática Médica; Argentina. | |
dc.description | Fil: Garnero, Analía. Hospital de Niños de la Santísima Trinidad. Servicio de Infectología, Córdoba; Argentina. | |
dc.description | Fil: Saka, Hector A. Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina. Centro de Investigaciones en Bioquímica Clínica e Inmunología. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. | |
dc.description | Fil: Galas, Marcelo. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio Antimicrobianos; Argentina. | |
dc.description | Fil: Bocco, Jose Luis. Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina. Centro de Investigaciones en Bioquímica Clínica e Inmunología. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. | |
dc.description | Fil: Corso, Alejandra. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio Antimicrobianos; Argentina. | |
dc.description | Fil: Sola, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina. Centro de Investigaciones en Bioquímica Clínica e Inmunología. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina. | |
dc.description | Fil: S. aureus Study Group; Argentina. | |
dc.description | Methicillin-resistant Staphylococcus aureus (MRSA) burden is increasing worldwide in hospitals [healthcare-associated (HA)-MRSA] and in communities [community-associated (CA)-MRSA]. However, the impact of CA-MRSA within hospitals remains limited, particularly in Latin America. A countrywide representative survey of S. aureus infections was performed in Argentina by analyzing 591 clinical isolates from 66 hospitals in a prospective cross-sectional, multicenter study (Nov-2009). This work involved healthcare-onset infections-(HAHO, >48 hospitalization hours) and community-onset (CO) infections [including both, infections (HACO) in patients with healthcare-associated risk-factors (HRFs) and infections (CACO) in those without HRFs]. MRSA strains were genetically typed as CA-MRSA and HA-MRSA genotypes (CA-MRSAG and HA-MRSAG) by SCCmec- and spa-typing, PFGE, MLST and virulence genes profile by PCR. Considering all isolates, 63% were from CO-infections and 55% were MRSA [39% CA-MRSAG and 16% HA-MRSAG]. A significantly higher MRSA proportion among CO- than HAHO-S. aureus infections was detected (58% vs 49%); mainly in children (62% vs 43%). The CA-MRSAG/HA-MRSAG have accounted for 16%/33% of HAHO-, 39%/13% of HACO- and 60.5%/0% of CACO-infections. Regarding the epidemiological associations identified in multivariate models for patients with healthcare-onset CA-MRSAG infections, CA-MRSAG behave like HA-MRSAG within hospitals but children were the highest risk group for healthcare-onset CA-MRSAG infections. Most CA-MRSAG belonged to two major clones: PFGE-type N-ST30-SCCmecIVc-t019-PVL(+) and PFGE-type I-ST5-IV-SCCmecIVa-t311-PVL(+) (45% each). The ST5-IV-PVL(+)/ST30-IV-PVL(+) clones have caused 31%/33% of all infections, 20%/4% of HAHO-, 43%/23% of HACO- and 35%/60% of CACO- infections, with significant differences by age groups (children/adults) and geographical regions. Importantly, an isolate belonging to USA300-0114-(ST8-SCCmecIVa-spat008-PVL(+)-ACME(+)) was detected for the first time in Argentina. Most of HA-MRSAG (66%) were related to the Cordobes/Chilean clone-(PFGE-type A-ST5-SCCmecI-t149) causing 18% of all infections (47% of HAHO- and 13% of HACO-infections). Results strongly suggest that the CA-MRSA clone ST5-IV-PVL(+) has begun to spread within hospitals, replacing the traditional Cordobes/Chilean-HA-MRSA clone ST5-I-PVL(-), mainly in children. Importantly, a growing MRSA reservoir in the community was associated with spreading of two CA-MRSA clones: ST5-IV-PVL(+), mainly in children with HRFs, and ST30-IV-PVL(+) in adults without HRFs. This is the first nationwide study in Argentina providing information about the molecular and clinical epidemiology of CA-MRSA, particularly within hospitals, which is essential for designing effective control measures in this country and worldwide. | |
dc.language | en | |
dc.relation | International journal of medical microbiology : IJMM | |
dc.rights | none | |
dc.subject | Argentina | |
dc.subject | Staphylococcus aureus Resistente a Meticilina | |
dc.subject | Staphylococcus aureus | |
dc.title | New patterns of methicillin-resistant Staphylococcus aureus (MRSA) clones, community-associated MRSA genotypes behave like healthcare-associated MRSA genotypes within hospitals, Argentina | |
dc.type | Artículo | |